Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Refactor Capital

Refactor Capital

Refactor Capital is an early-stage venture capital firm that invests in software companies.

Refactor Capital is a Burlingame, CA-based $50M early-stage venture capital firm that invests in areas such as applied biology, healthcare, crypto, food, wellness, transportation, aerospace, and more. The firm primarily invests in seed-stage companies.

As of March 2017, Refactor has invested in 20 software companies, half of them supporting healthcare and life sciences. Other areas represented in its portfolio are agriculture, financial, and legal services. The average check size is about $500,000, with the fund expecting to have around 40 to 50 companies in their portfolio.

As of January 2019, Refactor has 28 companies in its portfolio.

Timeline

Invested in

Associated Investment Funds

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date

David Lee is back with a new fund: Refactor Capital

Connie Loizos

Web

Refactor Capital cofounder highlights seed stage fund strategy - MedCity News

Stephanie Baum

Web

News

Title
Author
Date
Publisher
Description
Melia Russell
June 3, 2021
Business Insider
Zal Bilimoria, the sole partner at Refactor Capital, says the $50 million fund will be used to invest even more heavily in biotech and healthcare.
Erin Brodwin
November 4, 2019
Business Insider
Zal Bilimoria, the managing director of Silicon Valley venture firm Refactor Capital, told Business Insider that "biology is eating the whole world."

References

Golden logo
By using this site, you agree to our Terms & Conditions.